All In Biotech

Free tool

FAERS Monitor: Lexiscan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022161 or its brand name (Lexiscan, Regadenoson). Reports on generic versions are filed under their own applications.

Reports

4,773

Serious

2,655

56% of reports

Hospitalization

500

Death reported

130

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea511
  • dyspnoea409
  • injection site extravasation361
  • vomiting358
  • headache328
  • hypotension315
  • cardiac arrest284
  • dizziness276
  • seizure256
  • chest pain233
  • blood pressure decreased208
  • bradycardia196
  • loss of consciousness190
  • tremor188
  • unresponsive to stimuli164

Reports by year received

View as table
YearReports
2008144
2009104
201076
201155
2012425
2013514
2014473
2015301
2016380
2017418
2018424
2019315
2020250
2021175
2022209
2023188
2024155
2025103
202664

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,386 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
injection site extravasationSignal361132.8120.145,734
unresponsive to stimuliSignal16428.224.24,249
bradycardiaSignal19616.314.22,805
cardiac arrestSignal28415.213.63,757
blood pressure decreasedSignal20813.812.12,464
seizureSignal2569.88.72,017
hypotensionSignal3156.96.21,605
loss of consciousnessSignal1906.55.7891
chest painSignal2335.54.9871
tremorSignal1885.04.3601
vomitingSignal3583.43.0603
dyspnoeaSignal4093.22.9627
nauseaSignal5112.82.6634
dizzinessSignal2762.42.2238
headacheSignal3282.32.1249

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.